286 related articles for article (PubMed ID: 17487939)
1. Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations.
Audard V; Grimber G; Elie C; Radenen B; Audebourg A; Letourneur F; Soubrane O; Vacher-Lavenu MC; Perret C; Cavard C; Terris B
J Pathol; 2007 Jul; 212(3):345-52. PubMed ID: 17487939
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas.
Zucman-Rossi J; Benhamouche S; Godard C; Boyault S; Grimber G; Balabaud C; Cunha AS; Bioulac-Sage P; Perret C
Oncogene; 2007 Feb; 26(5):774-80. PubMed ID: 16964294
[TBL] [Abstract][Full Text] [Related]
3. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.
Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P
J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842
[TBL] [Abstract][Full Text] [Related]
4. Glutamine synthetase immunostaining correlates with pathologic features of hepatocellular carcinoma and better survival after radiofrequency thermal ablation.
Dal Bello B; Rosa L; Campanini N; Tinelli C; Torello Viera F; D'Ambrosio G; Rossi S; Silini EM
Clin Cancer Res; 2010 Apr; 16(7):2157-66. PubMed ID: 20233882
[TBL] [Abstract][Full Text] [Related]
5. Impaired E-cadherin expression and glutamine synthetase overexpression in solid pseudopapillary neoplasm of the pancreas.
Audard V; Cavard C; Richa H; Infante M; Couvelard A; Sauvanet A; Terris B; Paye F; Flejou JF
Pancreas; 2008 Jan; 36(1):80-3. PubMed ID: 18192886
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.
Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T
Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328
[TBL] [Abstract][Full Text] [Related]
7. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
[TBL] [Abstract][Full Text] [Related]
8. β-catenin plays a key role in metastasis of human hepatocellular carcinoma.
Lai TY; Su CC; Kuo WW; Yeh YL; Kuo WH; Tsai FJ; Tsai CH; Weng YJ; Huang CY; Chen LM
Oncol Rep; 2011 Aug; 26(2):415-22. PubMed ID: 21617877
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma.
Kim YD; Park CH; Kim HS; Choi SK; Rew JS; Kim DY; Koh YS; Jeung KW; Lee KH; Lee JS; Juhng SW; Lee JH
J Gastroenterol Hepatol; 2008 Jan; 23(1):110-8. PubMed ID: 18171349
[TBL] [Abstract][Full Text] [Related]
10. Wnt/beta-catenin signaling activates and determines hepatic zonal expression of glutathione S-transferases in mouse liver.
Giera S; Braeuning A; Köhle C; Bursch W; Metzger U; Buchmann A; Schwarz M
Toxicol Sci; 2010 May; 115(1):22-33. PubMed ID: 20118494
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of regenerating islet-derived 1 alpha and 3 alpha genes in human primary liver tumors with beta-catenin mutations.
Cavard C; Terris B; Grimber G; Christa L; Audard V; Radenen-Bussiere B; Simon MT; Renard CA; Buendia MA; Perret C
Oncogene; 2006 Jan; 25(4):599-608. PubMed ID: 16314847
[TBL] [Abstract][Full Text] [Related]
12. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J
Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417
[TBL] [Abstract][Full Text] [Related]
14. Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis.
Park JY; Park WS; Nam SW; Kim SY; Lee SH; Yoo NJ; Lee JY; Park CK
Liver Int; 2005 Feb; 25(1):70-6. PubMed ID: 15698401
[TBL] [Abstract][Full Text] [Related]
15. [Study on the role of Wnt/beta-catenin signaling transduction pathway in hepatocellular carcinoma cell line HepG2 and L02 cell line].
Wang QM; Jia LQ; Zhou HY; Li YS
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Oct; 23(10):926-8. PubMed ID: 17908501
[TBL] [Abstract][Full Text] [Related]
16. Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis.
Liu L; Zhu XD; Wang WQ; Shen Y; Qin Y; Ren ZG; Sun HC; Tang ZY
Clin Cancer Res; 2010 May; 16(10):2740-50. PubMed ID: 20460486
[TBL] [Abstract][Full Text] [Related]
17. A beta-catenin-dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors.
Loeppen S; Koehle C; Buchmann A; Schwarz M
Carcinogenesis; 2005 Jan; 26(1):239-48. PubMed ID: 15471898
[TBL] [Abstract][Full Text] [Related]
18. Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma.
Austinat M; Dunsch R; Wittekind C; Tannapfel A; Gebhardt R; Gaunitz F
Mol Cancer; 2008 Feb; 7():21. PubMed ID: 18282277
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of glutamine synthetase and cytochrome P450 isoforms in human hepatoblastoma.
Schmidt A; Braeuning A; Ruck P; Seitz G; Armeanu-Ebinger S; Fuchs J; Warmann SW; Schwarz M
Toxicology; 2011 Mar; 281(1-3):7-14. PubMed ID: 21237236
[TBL] [Abstract][Full Text] [Related]
20. The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules.
Rebouissou S; Couchy G; Libbrecht L; Balabaud C; Imbeaud S; Auffray C; Roskams T; Bioulac-Sage P; Zucman-Rossi J
J Hepatol; 2008 Jul; 49(1):61-71. PubMed ID: 18466996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]